Angiotensin II receptor blocker
- Angiotensin II receptor blockers (ARBs) are a class of medications used primarily in the management of hypertension (high blood pressure) and certain cardiovascular conditions.
- They work by blocking the action of angiotensin II, a hormone that constricts blood vessels and stimulates the release of aldosterone, leading to increased blood pressure.
- By inhibiting the effects of angiotensin II, ARBs help relax blood vessels, reduce blood pressure, and mitigate the strain on the cardiovascular system.

Mechanism of Action[edit]
- Angiotensin II exerts its effects by binding to specific receptors, namely angiotensin II type 1 receptors (AT1 receptors), located on the surface of blood vessels, heart muscle cells, and other tissues.
- ARBs selectively block these AT1 receptors, preventing angiotensin II from binding to them.
- By doing so, ARBs inhibit the vasoconstrictive and pro-inflammatory effects of angiotensin II.
Clinical Uses[edit]
The primary clinical applications of angiotensin II receptor blockers include:
Hypertension:
- ARBs are widely used as first-line agents in the treatment of hypertension. By relaxing blood vessels, they lower blood pressure and help maintain it within a target range.
Heart Failure:
- ARBs may be prescribed to patients with heart failure who cannot tolerate angiotensin-converting enzyme (ACE) inhibitors. They help reduce the workload on the heart by dilating blood vessels and improving cardiac function.
Diabetic Nephropathy:
- ARBs are effective in slowing the progression of diabetic nephropathy, a common complication of diabetes characterized by kidney damage.
- They can help preserve kidney function and reduce proteinuria (presence of excess protein in the urine) in patients with diabetes.
Post-Myocardial Infarction:
- Following a myocardial infarction (heart attack), ARBs may be prescribed to certain patients to improve outcomes and reduce the risk of future cardiovascular events.
Examples of ARBs[edit]
Several angiotensin II receptor blockers are available on the market, including:
Adverse Effects[edit]
Common side effects associated with angiotensin II receptor blockers include:
- dizziness, fatigue, headache, and gastrointestinal symptoms such as nausea and diarrhea. In rare cases, more serious adverse effects, such as angioedema (swelling of the face, lips, tongue, or throat), allergic reactions, and changes in kidney function, may occur.
Precautions and Contraindications[edit]
Some precautions and contraindications include:
- Pregnancy: ARBs should generally be avoided during pregnancy due to the potential risk of harm to the developing fetus.
- Renal Impairment: Dose adjustments may be necessary in individuals with impaired kidney function to prevent further deterioration of renal function.
- Hyperkalemia: ARBs can increase potassium levels in the blood. Close monitoring is needed, particularly in patients with pre-existing hyperkalemia or conditions that may predispose them to elevated potassium levels.
- Drug Interactions: ARBs may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), potassium-sparing diuretics, and certain antihypertensive drugs. Close monitoring and appropriate dose adjustments may be required.
References[edit]
Gradman, A.H., & Basile, J.N. (2017). Angiotensin receptor blockers. In Drug Therapy for Hypertension (pp. 99-118). Springer. Unger, T. (2002). The role of the renin-angiotensin system in the development of cardiovascular disease. American Journal of Cardiology, 89(2A), 3A-9A. Lexicomp Online. Angiotensin II Receptor Blockers (ARBs).
See Also[edit]
- Angiotensin-Converting Enzyme Inhibitors
- Renin-Angiotensin-Aldosterone System
- Hypertension
- Heart Failure
- Diabetic Nephropathy
- Myocardial Infarction
- Antihypertensive Medications
- Hyperkalemia
| Major chemical drug groups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Pharmacomodulation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Angiotensin receptor modulators | ||||
|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian